Hypoadrenalism, more commonly called adrenal insufficiency, occurs when the adrenal glands fail to produce enough cortisol and, in some forms, aldosterone. The condition has several distinct causes, a notoriously vague symptom profile that leads to years of misdiagnosis, and a treatment regimen centered on daily hormone replacement that most people must continue for life. Despite being well understood at a biological level, adrenal insufficiency remains surprisingly tricky in practice, both for the clinician trying to pin down the diagnosis and for the patient trying to feel well on replacement therapy.
Why the Adrenal Glands Stop Working
The causes of adrenal insufficiency split into three broad categories depending on where the problem originates. Primary adrenal insufficiency (historically called Addison’s disease) means the adrenal glands themselves are damaged. Secondary adrenal insufficiency means the pituitary gland in the brain isn’t sending the right signals. And the single most common cause of adrenal insufficiency overall is neither of these in the traditional sense: it’s the use of prescription glucocorticoid medications, which can suppress the body’s own cortisol production through any route of administration, whether oral, inhaled, topical, nasal, or injected into a joint.1PubMed Central. Glucocorticoid Withdrawal-An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice
Among people with primary adrenal insufficiency in industrialized countries, autoimmune destruction of the adrenal cortex accounts for roughly 75 to 96 percent of cases. The immune system targets an enzyme called 21-hydroxylase, gradually destroying the cells that produce cortisol and aldosterone.2European Journal of Endocrinology. The natural history of 21-hydroxylase autoantibodies in autoimmune Addison’s disease In parts of the world where tuberculosis is still common, TB-related destruction of both adrenal glands remains a leading cause. In fact, TB was the very first cause of adrenal failure ever described, when Thomas Addison documented the disease in 1855.3PubMed Central. Current Approach for Diagnosis and Treatment of Adrenal Tuberculosis-Our Experience and Review of Literature
Less common causes include rare genetic conditions. In children with primary adrenal insufficiency who don’t have congenital adrenal hyperplasia, genetic mutations in a handful of specific genes account for most cases, with mutations in the ABCD1 gene being the most frequent in one pediatric series.4PubMed Central. The etiology and clinical features of non-CAH primary adrenal insufficiency in children ABCD1 mutations cause X-linked adrenoleukodystrophy, a progressive neurological disorder in which adrenal failure occurs in about 70 percent of affected males.5PubMed Central. X-linked adrenoleukodystrophy and primary adrenal insufficiency These genetic forms are individually rare but collectively important, especially when adrenal insufficiency appears in a young boy or a man without obvious autoimmune markers.
Immune Checkpoint Inhibitors as an Emerging Cause
A newer and increasingly recognized cause of secondary adrenal insufficiency is cancer treatment with immune checkpoint inhibitors. These drugs, widely used in melanoma and other cancers, work by releasing the brakes on the immune system. The flip side is that the unleashed immune response sometimes attacks the pituitary gland, causing inflammation known as hypophysitis, or it selectively knocks out the pituitary cells that produce ACTH, the hormone that signals the adrenals to make cortisol. As checkpoint inhibitor use grows, endocrine side effects like these are expected to become more common.6PubMed. Secondary Adrenal Insufficiency and Multisystem Endocrinopathy Following Immune Checkpoint Inhibitor Therapy Unlike autoimmune Addison’s disease, checkpoint-inhibitor-related adrenal insufficiency tends to come on suddenly, sometimes within weeks of starting treatment, which makes awareness among oncology teams especially important.
Why It Gets Missed for So Long
One of the most frustrating aspects of adrenal insufficiency is how long people suffer before anyone figures out what’s wrong. The symptoms are real and often debilitating, but they’re also maddeningly nonspecific: fatigue, nausea, weight loss, low appetite, dizziness on standing, vague abdominal discomfort, and sometimes muscle or joint pain. None of these screams “adrenal problem” to a clinician encountering them for the first time.
A cross-sectional study of 216 patients with adrenal insufficiency found that fewer than 30 percent of women and about half of men were diagnosed within the first six months after symptoms began. A full 20 percent went more than five years before receiving the correct diagnosis. More than two-thirds had seen at least three doctors before someone got it right, and 68 percent had initially been given a wrong diagnosis, most commonly a psychiatric or gastrointestinal condition.7PubMed. Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients
The gastrointestinal misdiagnosis track is especially common. Loss of appetite and weight loss tend to be among the earliest symptoms, and the resulting workup often leads clinicians toward suspected ulcer disease. In one series, a third of adrenal insufficiency patients underwent endoscopy and nearly half were put on long-term acid-reducing medication for presumed gastritis before the real cause was identified.8PubMed Central. Delay in Diagnosis of Adrenal Insufficiency Is a Frequent Cause of Adrenal Crisis The danger of this diagnostic delay isn’t just years of feeling terrible. It’s that an undiagnosed patient can tip into adrenal crisis during a stressful event, an illness, or surgery, with life-threatening consequences.
How Primary and Secondary Differ in Practice
The distinction between primary and secondary adrenal insufficiency matters beyond the academic. In primary disease, the adrenal glands themselves are destroyed, so both cortisol and aldosterone production fail. Aldosterone is the hormone that keeps sodium and potassium in balance and helps maintain blood pressure, which is why people with Addison’s disease often crave salt, feel dizzy when they stand up, and may have dangerously high potassium levels. They also tend to develop darkened skin, especially in skin creases, scars, and the inside of the cheeks, because the pituitary pumps out excess ACTH in a futile attempt to stimulate the failing adrenals, and ACTH cross-reacts with pigment receptors in the skin.
In secondary adrenal insufficiency, the pituitary or hypothalamus is the problem, so ACTH is low rather than high. Skin darkening doesn’t occur. Aldosterone production usually stays intact because it’s primarily regulated by a separate system involving the kidneys, so severe salt wasting and hyperkalemia are less common. A stimulated aldosterone level can actually help clinicians distinguish between the two forms, with research showing that a particular cutoff during a stimulation test had about 88 percent sensitivity and roughly 90 percent specificity for separating primary from secondary disease.9PubMed Central. Primary vs secondary adrenal insufficiency: ACTH-stimulated aldosterone diagnostic cut-off values by tandem mass spectrometry
Making the Diagnosis
Diagnosing adrenal insufficiency usually starts with a morning blood cortisol level. A very low result is suggestive, but borderline values need further testing. The gold standard for assessing whether the entire hormonal axis from hypothalamus to pituitary to adrenal is working is the insulin tolerance test, which involves inducing mild low blood sugar and seeing whether cortisol rises in response. It’s considered the best test but is rarely used in practice because of safety concerns, particularly in older adults or people with heart disease or seizure disorders.10PubMed Central. ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow
Instead, most clinicians rely on the ACTH stimulation test, in which a synthetic version of ACTH is injected and cortisol is measured 30 or 60 minutes later. If the adrenals respond well, the cortisol should rise above a threshold, historically set around 18 micrograms per deciliter. But there’s real debate about where exactly to draw that line. One study in patients with pituitary lesions found that using a stricter cutoff of about 14.6 micrograms per deciliter, only 5 percent met criteria for secondary adrenal insufficiency, but applying the traditional 18 microgram cutoff, that figure jumped to over 18 percent.11PubMed. The 1 μg Synacthen stimulation test in the diagnosis of secondary adrenal insufficiency in patients with Rathke’s cleft cyst and empty sella syndrome The choice of cutoff, the dose of synthetic ACTH used, the timing of blood draws, and even the type of cortisol assay all introduce variability, which is why the test’s accuracy for secondary adrenal insufficiency remains a source of ongoing clinical discussion.
The Basics of Replacement Therapy
Treatment for adrenal insufficiency centers on replacing the hormones the body can no longer make. For cortisol, the standard drug is hydrocortisone, taken two or three times a day to roughly mimic the body’s normal daily cortisol output. Some patients and clinicians prefer prednisolone or prednisone instead, since these synthetic steroids last longer and can be taken once or twice daily, though they are harder to fine-tune.
People with primary adrenal insufficiency also need a mineralocorticoid, typically fludrocortisone, taken once daily at doses ranging from 0.05 to 0.20 milligrams to maintain sodium-potassium balance and blood pressure.12PubMed. Replacement therapy for Addison’s disease: recent developments Patients with secondary adrenal insufficiency usually don’t need fludrocortisone because their aldosterone pathway remains functional.
One limitation of conventional hydrocortisone tablets is that they can’t perfectly replicate the body’s natural cortisol rhythm. Healthy cortisol levels rise sharply in the early morning hours, peak around waking, and taper through the day. Splitting hydrocortisone into two or three doses gets you in the right ballpark, but the peaks and troughs are still jagged compared with what the body would normally produce.
Modified-Release Formulations and Newer Approaches
Researchers have developed modified-release hydrocortisone tablets that come closer to mimicking the body’s cortisol curve. These formulations release the drug gradually over hours rather than all at once, and studies have shown they can better replicate the circadian cortisol rhythm and improve control of adrenal androgen levels, particularly in conditions like congenital adrenal hyperplasia.13PubMed Central. Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy One such product, Efmody, was specifically designed to replicate the diurnal cortisol pattern and has been approved for use in congenital adrenal hyperplasia.14PubMed Central. Chronotherapy based on modified-release hydrocortisone to restore the physiological cortisol diurnal rhythm
An even more experimental approach involves delivering hydrocortisone through a subcutaneous pump, similar to the insulin pumps used for diabetes. This would allow programmable delivery throughout the day, potentially recreating both the daily rhythm and the shorter pulsatile bursts of cortisol that the body normally produces.15The Journal of Clinical Endocrinology & Metabolism. Extended-release Hydrocortisone Formulations—Is There a Clinically Meaningful Benefit? These pumps are not yet in widespread clinical use, but they represent a conceptually elegant solution for patients who struggle with conventional dosing.
DHEA Replacement and the Androgen Gap
The adrenal glands also produce DHEA, a precursor to sex hormones. In primary adrenal insufficiency, DHEA production nearly vanishes along with cortisol and aldosterone, but standard replacement therapy doesn’t address this. The question of whether adding DHEA makes patients feel better has been studied for over two decades, and the answer remains frustratingly unclear.
A long-term randomized controlled trial in Addison’s disease patients found that DHEA supplementation raised blood levels of DHEA and related androgens, with testosterone reaching low-normal levels in women specifically. The investigators reported some beneficial effects, though the results were described as supporting further study rather than as definitive proof.16PubMed Central. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial Other reviews have noted that the overall evidence on DHEA and quality of life is inconsistent, with some trials showing improvement and others showing none. The current consensus is that DHEA, or possibly testosterone supplementation, may help selected patients but isn’t routinely recommended for everyone with Addison’s disease.12PubMed. Replacement therapy for Addison’s disease: recent developments
Stress Dosing and Sick Day Rules
Perhaps the most important practical knowledge for someone with adrenal insufficiency is knowing when and how to increase their glucocorticoid dose. A healthy body responds to physical stress like fever, injury, vomiting, or surgery by ramping up cortisol production, sometimes to several times the normal level. A person on fixed-dose hydrocortisone can’t do this, which creates a dangerous gap during illness or trauma.
The standard guidance for minor illnesses with fever is to double or triple the usual hydrocortisone dose for the duration of the illness, then taper back to normal once you feel better. For vomiting or diarrhea that prevents you from absorbing oral medication, an emergency injection of hydrocortisone is critical, which is why most patients are prescribed an injectable kit to keep at home. The rules sound simple, but they require real-time judgment about severity, and many patients report anxiety about whether they’re adjusting correctly.
For surgery, the traditional practice was to give very high doses of hydrocortisone before and during the procedure. More recent pharmacokinetic research has called this into question, suggesting that cortisol behaves differently in the post-operative period and that lower doses than traditionally used can be safely administered even during major surgery.17PubMed. Perioperative Glucocorticoid Therapy for Patients with Adrenal Insufficiency: Dosing Based on Pharmacokinetic Data This is an area where practice is still catching up with the evidence, and many surgical teams continue to use older, more aggressive supplementation protocols.
Bone Health on Long-Term Replacement
Because the treatment for adrenal insufficiency involves taking steroids every day for life, a natural concern is whether replacement doses carry the same bone-thinning risks as the higher doses used to suppress inflammation. It’s well established that people on therapeutic doses of glucocorticoids for conditions like rheumatoid arthritis or asthma are at increased risk for osteoporosis. Whether the much lower replacement doses used in Addison’s disease carry the same risk is less settled. The evidence to date has been described as equivocal, with some studies finding modest reductions in bone density and others finding none.18PubMed. Predictors of bone mineral density in patients receiving glucocorticoid replacement for Addison’s disease
The practical takeaway is that bone health monitoring makes sense for anyone on lifelong glucocorticoid replacement, but the risk profile is clearly different from that of someone on high-dose steroids for inflammation. Overreplacement, taking more hydrocortisone than needed, is the main modifiable risk factor. This is one reason clinicians emphasize using the lowest effective replacement dose rather than erring on the high side.
The Quality-of-Life Problem
Even with what should be adequate hormone replacement, many people with adrenal insufficiency don’t feel fully well. Fatigue, cognitive sluggishness, and reduced stamina are common complaints that persist despite normal cortisol levels on blood work. This quality-of-life gap is one of the least understood and most frustrating aspects of the disease.
The consequences extend beyond how patients feel day to day. Research has documented that adrenal insufficiency is associated with higher rates of unemployment compared with the general population. One study found that 40 percent of patients had changed their work situation because of their disease, with 18 percent receiving disability pensions, compared with about 4 percent of the general population. In a separate survey, 44 percent of patients with adrenal insufficiency attributed their condition as the cause of financial burden, and 10 percent said it made them unable to work entirely.19Endocrinology and Metabolism Clinics of North America. Quality of Life in Adrenal Insufficiency
Why replacement therapy doesn’t fully restore wellbeing isn’t entirely clear. Part of the answer is almost certainly the imperfect cortisol rhythm achieved with pills, since the normal body delivers cortisol in a dynamic, pulsatile fashion that no tablet can fully replicate. The missing DHEA may play a role in some patients. And the psychological burden of living with a condition that can become life-threatening during any ordinary illness or injury is itself exhausting.
Living with Adrenal Insufficiency on a Practical Level
Beyond the medical details, daily life with adrenal insufficiency involves a set of practical habits that healthy people never think about. You learn to carry a medical alert card or bracelet, to keep an emergency injection kit accessible at all times, and to mentally rehearse what to do if you start vomiting and can’t keep your medication down. Travel requires planning around time zones, since your dosing schedule is tied to your body clock. Hot weather and heavy sweating can increase your need for fludrocortisone and salt. Even a dental procedure or a stressful exam may warrant a small dose adjustment.
Many patients describe an ongoing negotiation with their own energy levels, learning to pace activities and anticipate the post-exertion fatigue that often hits harder than it would for someone with healthy adrenals. Support communities and patient organizations have become important resources, both for practical advice about managing the condition and for the psychological reassurance that comes from connecting with others who share the same challenges. The gap between how straightforward adrenal insufficiency looks on paper and how it actually feels to manage is something that clinicians are increasingly recognizing, even if closing that gap remains a work in progress.